Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Rapid Dose Therapeutics Corp. has announced an extension for closing its up to $6 million equity private placement financing, with potential issuance of over 35 million shares at $0.17 each. The Canadian biotech company specializes in innovative drug delivery systems, including their flagship QuickStrip™ product, an orally dissolvable film for rapid active ingredient release into the bloodstream.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.
